December2016

News Hour According to IOM’s first regional analysis of displacement trends in the Lake Chad Basin crisis triggered by the Boko Haram insurgency, 2,635,450 individuals are now displaced in the region, both internally...

News Hour The humanitarian community will soon be able to better coordinate support for northeast Nigeria, where nearly seven million people are in need of life-saving assistance. This is thanks to the setting...

News Hour The Asian Development Bank (ADB) has approved a $106.51 million loan to support the development of the five Viet Nam Development Triangle Area (VDTA) provinces — Binh Phuoc, Dak Lak, Dak...

News Hour Britain’s Anthony Joshua set up an April showdown with veteran heavyweight Wladimir Klitschko on Saturday after retaining his IBF world title with a clinical third round stoppage of outclassed American Eric...

News Hour Indian fast bowler Mohammed Shami and wicketkeeper Wriddhiman Saha will remain out of action for India’s fifth and final Test against England, the national cricket board said Sunday.    The Board...

News Hour: CRYSTAL was a prospective, multicenter, 12-week, randomized, pragmatic, open-label trial. Patients were recruited into four groups according to previous medication and symptoms, and randomized to a direct switch to Seebri® Breezhaler®...

News Hour: People with chronic opioid use disorders are more likely to relapse and do so sooner if they are treated in a compulsory drug detentioncentre rather than a voluntary drug treatment centre...

News Hour: A new drug for spinal muscular atrophy has shown promising early results in a phase 2 trial involving 20 babies with infantile-onset spinal muscular atrophy. The study, published in The Lancet,...

News Hour: Novartis announced at the 58th American Society of Hematology (ASH) Annual Meeting & Exposition new data from the Tasigna® (nilotinib) ENESTop Treatment-free Remission (TFR) study, which demonstrate that TFR rates are...

News Hour: Myeloproliferative neoplasms (MPNs) are a group of related and rare blood cancers in which bone marrow cells responsible for the body’s blood cells develop and function abnormally. Specific MPN conditions include...